These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1004531)

  • 61. Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles.
    Aguado MT; Lambert PH
    Immunobiology; 1992 Feb; 184(2-3):113-25. PubMed ID: 1587538
    [No Abstract]   [Full Text] [Related]  

  • 62. [An experimental study of the effect of biopolymers on the course of an inflammatory process in the oral mucosa].
    Khomenko LA; Antonishin BV; Rakhniĭ ZhI
    Stomatologiia (Mosk); 1992; (2):20-3. PubMed ID: 1412533
    [No Abstract]   [Full Text] [Related]  

  • 63. Long-acting delivery systems for narcotic antagonists. 1.
    Woodland JH; Yolles S; Blake DA; Helrich M; Meyer FJ
    J Med Chem; 1973 Aug; 16(8):897-901. PubMed ID: 4745832
    [No Abstract]   [Full Text] [Related]  

  • 64. Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers.
    Peterson GM
    Neurobiol Aging; 1989; 10(5):639-40; discussion 648-50. PubMed ID: 2812244
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preparation and in vitro evaluation of a sustained-action suspension of dextromethorphan.
    Smith WE; Buehler JD; Robinson MJ
    J Pharm Sci; 1970 Jun; 59(6):776-9. PubMed ID: 5423075
    [No Abstract]   [Full Text] [Related]  

  • 66. New approach to development and manufacture of enteric compression coatings.
    Srinivas R; DeKay HG; Banker GS
    J Pharm Sci; 1966 Mar; 55(3):335-40. PubMed ID: 5960182
    [No Abstract]   [Full Text] [Related]  

  • 67. Acute toxicity as a method of assessing sustained release preparations.
    SHENOY KG; GRICE HC; CAMPBELL JA
    Toxicol Appl Pharmacol; 1960 Jan; 2():100-10. PubMed ID: 14445819
    [No Abstract]   [Full Text] [Related]  

  • 68. [PROLONGED ACTION PREPARATIONS].
    CHAO SS; HSI NC
    Yao Xue Xue Bao; 1962 Sep; 9():562-76. PubMed ID: 14074972
    [No Abstract]   [Full Text] [Related]  

  • 69. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
    Bisaga A; Mannelli P; Sullivan MA; Vosburg SK; Compton P; Woody GE; Kosten TR
    Am J Addict; 2018 Apr; 27(3):177-187. PubMed ID: 29596725
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?
    Nunes EV; Krupitsky E; Ling W; Zummo J; Memisoglu A; Silverman BL; Gastfriend DR
    J Addict Med; 2015; 9(3):238-43. PubMed ID: 25901451
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The development of sustained action preparations of narcotic antagonists.
    Willette RE
    NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531
    [No Abstract]   [Full Text] [Related]  

  • 73. Background on animal testing in the drug delivery systems program.
    Dewey WL
    NIDA Res Monogr; 1981; 28():69-76. PubMed ID: 6791014
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sustained release of naltrexone from glyceride implants.
    Sullivan MF; Kalkwarf DR
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):27-32. PubMed ID: 967232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Narcotic antagonists: the search for long-acting preparations: introduction.
    Willette RE
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):1-5. PubMed ID: 827708
    [No Abstract]   [Full Text] [Related]  

  • 76. Development of Chronomers tm for narcotic antagonists.
    Capozza RC; Schmitt EE; Seńdelbeck LR
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):39-42. PubMed ID: 967234
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.